These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6508861)

  • 1. D-penicillamine in patients with rheumatoid arthritis. Serum levels, pharmacokinetic aspects, and correlation with clinical course and side effects.
    Muijsers AO; van de Stadt RJ; Henrichs AM; Ament HJ; van der Korst JK
    Arthritis Rheum; 1984 Dec; 27(12):1362-9. PubMed ID: 6508861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis.
    Matthey F; Perrett D; Greenwood RN; Baker LR
    Clin Nephrol; 1986 May; 25(5):268-71. PubMed ID: 3720037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood levels and side-effects of D-penicillamine.
    Van Der Korst JK; Muijsers AO; Henrichs AM; Ament HJ; Van De Stadt RJ
    Agents Actions Suppl; 1979; (5):159-67. PubMed ID: 294133
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of the major metabolites of D-penicillamine in patients with rheumatoid arthritis.
    Carruthers G; Harth M; Freeman D; Weir D; Rothwell R; Butler M
    Clin Invest Med; 1984; 7(1):35-40. PubMed ID: 6723122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term use of D-penicillamine for treating rheumatoid arthritis: is continuous therapy necessary?
    Doyle DV; Perrett D; Foster OJ; Ensor M; Scott DL
    Br J Rheumatol; 1993 Jul; 32(7):614-7. PubMed ID: 8339135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the metabolism of D-penicillamine and its interaction with probenecid in cystinuria and rheumatoid arthritis.
    Yu TF; Roboz J; Johnson S; Kaung C
    J Rheumatol; 1984 Aug; 11(4):467-70. PubMed ID: 6481720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resumption of treatment with penicillamine after proteinuria.
    Hill H; Hill A; Davison AM
    Ann Rheum Dis; 1979 Jun; 38(3):229-31. PubMed ID: 485579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis.
    Brooks PM; Miners JO; Smith K; Smith MD; Fearnley I; Birkett DJ
    J Rheumatol; 1984 Dec; 11(6):772-5. PubMed ID: 6520830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacology and mechanism of action of D-penicillamine in rheumatoid polyarthritis].
    Clerc D; Sallière D; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1983 May; 50(6):457-63. PubMed ID: 6351235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of D-penicillamine in rheumatoid arthritis. Dose effect and the role of zinc.
    Mery C; Delrieu F; Ghozlan R; Saporta L; Simon F; Amor B; Menkes CJ; Delbarre F
    Scand J Rheumatol; 1976; 5(4):241-7. PubMed ID: 795022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolism and pharmacology of D-penicillamine in man.
    Perrett D
    J Rheumatol Suppl; 1981; 7():41-50. PubMed ID: 7014876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine.
    Dixon JS; Pickup ME; Lowe JR; Hallett C; Lee MR; Wright V
    Ann Rheum Dis; 1980 Aug; 39(4):301-11. PubMed ID: 7436556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of D-penicillamine in serum and urine of patients with rheumatoid arthritis.
    Muijsers AO; Van de Stadt RJ; Henrichs AM; Van der Korst JK
    Clin Chim Acta; 1979 Jun; 94(2):173-80. PubMed ID: 455728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillamine in rheumatoid arthritis.
    Hill AG; Hill HF
    Agents Actions Suppl; 1979; (5):129-38. PubMed ID: 393102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [D-penicillamine--a current review of areas of use and dosage guidelines].
    Sörensen H
    Z Rheumatol; 1988; 47 Suppl 1():13-6. PubMed ID: 3063002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of rheumatoid arthritis using D-penicillamine].
    Ott VR; Schmidt KL
    Internist (Berl); 1974 Jun; 15(6):328-35. PubMed ID: 4211090
    [No Abstract]   [Full Text] [Related]  

  • 17. D-penicillamine withdrawal in rheumatoid arthritis.
    Ahern MJ; Hall ND; Case K; Maddison PJ
    Ann Rheum Dis; 1984 Apr; 43(2):213-7. PubMed ID: 6370151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-penicillamine treatment in rheumatoid arthritis monitored by plasma alfa-1-antitrypsin-IgA complexes and plasma and urinary sulphur containing aminoacids.
    Wollheim FA; Jeppsson JO; Laurell CB
    Scand J Rheumatol Suppl; 1979; (28):21-7. PubMed ID: 313074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillamine treatment in rheumatoid arthritis. A retrospective study.
    Börjesson O; Knutsson LP; Svensson B
    Acta Med Scand; 1980; 207(1-2):93-6. PubMed ID: 7368979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of D-penicillamine therapy in chronic polyarthritis].
    Franke M; Menning H; Ströbel G
    Z Rheumatol; 1981; 40(2):54-61. PubMed ID: 7282106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.